Impact Factor
3.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.28
717 total citations
h5-index
35
h5 depth signal
Cited share
90.7%
156 of 172
Total citations
717
Citation footprint
Metric signal
5.14
External metric anchor
Self-citation
15.8%
113 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
398
China
155
United Kingdom
114
Italy
78
Germany
57
Citing Fields of Research
Allergies
304
Lung Cancer
268
Respiratory Support
222
Auto-Inflammatory Disorders
184
Cardiology
79
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,908
Articles tracked across the journal lifetime
Indexed publication set
172
156 cited publications
Last 12 months
87
7.3 publications/month
Open access share
50.6%
44 OA publications in the last year
Leading citing country
United States
398 citing publications
Leading citing field
Allergies
304 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v154n1, Dec. 29, 1976-
v154n1, Dec. 29, 1976-
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Lung Cancer
Auto-Inflammatory Disorders
Respiratory Support
Immunology
Issuing & Sponsoring Bodies
Contributor
Gesellschaft für Lungen- und Atmungsforschung (Germany)
Broad Categories
Pulmonary Medicine
Allergies
Auto-Inflammatory Disorders
Cystic Fibrosis
Lung Cancer
Cardiology
MeSH Descriptors
Lung Diseases
Lung
Respiration
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1007/s00408-026-00949-0
Open DOI
Sample Adequacy PD-L1 and NGS in NSCLC: Shape-Sensing Robotic Assisted Bronchoscopy Versus CT Guided Lung Biopsy
04
DOI 10.1007/s00408-026-00946-3
Open DOI
Contemporary Chemotherapy Benchmarks for Molecularly Defined Advanced NSCLC: Reconstructed Individual Patient-Level Data of 22 Randomized Trials
Purpose: The increasing adoption of targeted therapies over chemotherapy has made randomized controlled trials (RCT) with chemotherapy increasingly challenging in advanced NSCLC with actionable genomic alterations (AGA), particularly for...
05
06
07
DOI 10.1007/s00408-026-00945-4
Open DOI
Therapeutic Treatment with a Clinically Relevant Dose of Dexamethasone Reduces Pulmonary Vascular Leak in a Mouse Model of ARDS
Purpose Acute Respiratory Distress Syndrome (ARDS) is a life-threatening acute lung injury with great unmet medical needs. Lung edema resulting from increased vascular leak is a hallmark of the disease. Recently corticosteroids were reco...
08
DOI 10.1007/s00408-026-00944-5
Open DOI
Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis
Background Lymphangioleiomyomatosis (LAM) is a rare, progressive cystic lung disease that affects women of reproductive age. Although registries from Western countries have provided key insights, comprehensive nationwide data from Asian ...
09
10
Bibliographical & Catalog Notes
Also issued online.
Articles mainly in English with some in German; summaries in English and German.
Official organ of the Gesellschaft für Lungen- und Atmungsforschung.
(1988)19890818 Notice published Printed on acid-free paper